X4 Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
XFOR Key Statistics
Stock Snapshot
As of today, X4 Pharmaceuticals(XFOR) shares are valued at $2.91. The company's market cap stands at 288.52M, with a P/E ratio of -2.44.
On 2026-10-10, X4 Pharmaceuticals(XFOR) stock moved within a range of $2.80 to $2.96. With shares now at $2.91, the stock is trading +3.9% above its intraday low and -1.7% below the session's peak.
Trading volume for X4 Pharmaceuticals(XFOR) stock has reached 541.2K, versus its average volume of 887.98K.
Over the past 52 weeks, X4 Pharmaceuticals(XFOR) stock has traded between a high of $4.83 and a low of $2.70.
Over the past 52 weeks, X4 Pharmaceuticals(XFOR) stock has traded between a high of $4.83 and a low of $2.70.
XFOR News
X4 Pharmaceuticals ( (XFOR) ) has provided an update. On October 7, 2026, X4 Pharmaceuticals entered a senior secured term loan agreement with K2 HealthVenture...
X4 Pharmaceuticals (XFOR) said it entered into a senior secured term loan facility of up to $150M with K2 HealthVentures, replacing its previous loan agreement...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.